Abstract: The present disclosure generally relates to methods, and diagnostic applications, for the treatment of ulcerative colitis. More particularly the methods and diagnostic applications of the present invention relate to expression profiles of certain gene transcripts in ulcerative colitis patients and the usefulness of the expression profiles of these gene transcripts for the treatment, and/or diagnostic use in a subgroup of patients having ulcerative colitis.
| # | Name | Date |
|---|---|---|
| 1 | 202517090342-STATEMENT OF UNDERTAKING (FORM 3) [22-09-2025(online)].pdf | 2025-09-22 |
| 3 | 202517090342-Sequence Listing in PDF [22-09-2025(online)].pdf | 2025-09-22 |
| 4 | 202517090342-REQUEST FOR EXAMINATION (FORM-18) [22-09-2025(online)].pdf | 2025-09-22 |
| 5 | 202517090342-RELEVANT DOCUMENTS [22-09-2025(online)].pdf | 2025-09-22 |
| 6 | 202517090342-POWER OF AUTHORITY [22-09-2025(online)].pdf | 2025-09-22 |
| 7 | 202517090342-MARKED COPIES OF AMENDEMENTS [22-09-2025(online)].pdf | 2025-09-22 |
| 8 | 202517090342-FORM 18 [22-09-2025(online)].pdf | 2025-09-22 |
| 9 | 202517090342-FORM 13 [22-09-2025(online)].pdf | 2025-09-22 |
| 10 | 202517090342-FORM 1 [22-09-2025(online)].pdf | 2025-09-22 |
| 11 | 202517090342-DECLARATION OF INVENTORSHIP (FORM 5) [22-09-2025(online)].pdf | 2025-09-22 |
| 12 | 202517090342-COMPLETE SPECIFICATION [22-09-2025(online)].pdf | 2025-09-22 |
| 13 | 202517090342-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [22-09-2025(online)].pdf | 2025-09-22 |
| 14 | 202517090342-AMMENDED DOCUMENTS [22-09-2025(online)].pdf | 2025-09-22 |
| 15 | 202517090342-Proof of Right [23-09-2025(online)].pdf | 2025-09-23 |